# Bunge Limited (BG) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Consumer Defensive / Household Products. Price $118.71, market value $22.8 billion.

## Valuation
- **P/E (trailing): 25.6×** (5-yr avg 9.6×, 3-yr avg 11.2×). Bunge Limited trades at 25.6× trailing earnings, well above its own five-year average of 9.6×: investors are paying up relative to the company's past. The Consumer Defensive median in the September 2026 study was 20.1×. Forward P/E is 10.5×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.4×**. The shares trade at 1.4× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -3.1%** (5-yr avg -11.2%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 3.9%**. The inverse of the P/E: 3.9% of the price is earned each year.

## Profitability
- **Gross margin: 11.9%**. Bunge Limited keeps 11.9% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Net margin: 4.8%**. 4.8% of each dollar of sales reaches the bottom line.
- **Return on equity: 5.1%**. 5.1% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 2.3%**. Each dollar of assets produces 2.3% of profit.

## Growth
- **Revenue growth (1 yr): 9.0%** (3-yr -7.0%/yr). Revenue grew 9.0% over the last year.
- **EPS growth (1 yr): -38.5%** (3-yr -22.4%/yr). Earnings per share fell 38.5%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.88**. Debt is 0.88 times equity, moderate leverage.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 2.43%** ($2.84 per share, trailing). Bunge Limited yields 2.43%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 56%**. 56% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 24**. 24 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 6.8%/yr** (1-yr 2.8%). The dividend has grown 6.8% a year over five years.

## Price and momentum
- **Total return (1 yr): 49.1%** (YTD 34.8%, 3-mo -6.1%). The shares are up 49.1% over twelve months including dividends.
- **From 52-week high: -12.0%** (56.2% above the low). Trading 12% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 57**. An RSI of 57 is neutral.
- **Beta (1 yr): -0.05** (volatility 32%). Beta of -0.05 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BG · Page: https://foliofundamentals.com/stocks/bg

Not investment advice.